The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Research Funding - Amgen; Janssen; Novartis; Takeda
Addressing unmet medical needs in maintenance treatment for newly diagnosed multiple myeloma (NDMM).
 
Wee Joo Chng
Honoraria - Amgen; Celgene; Janssen; Novartis; Roche; Takeda
Research Funding - ASLAN Pharmaceuticals; Celgene; Janssen
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Roche; Takeda
 
Meral Beksac
Consulting or Advisory Role - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Novartis (Inst); Takeda (Inst)
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag
 
Roman Hajek
No Relationships to Disclose
 
Katja Weisel
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Juno Therapeutics; Sanofi; Takeda
Research Funding - Amgen; Celgene; Janssen; Sanofi
 
Maria-Victoria Mateos
Honoraria - Amgen; Celgene; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Takeda
 
Andrew Spencer
Honoraria - Takeda
Research Funding - Takeda
 
Shinsuke Iida
Honoraria - Bristol-Myers Squibb; Celgene; Janssen; Novartis; Ono Pharmaceutical; Takeda
Consulting or Advisory Role - Janssen; Ono Pharmaceutical; Sanofi; Takeda
Research Funding - Abbvie; Bristol-Myers Squibb; Celgene; Chugai Pharma; Gilead Sciences; Janssen; Kyowa Hakko Kirin; MSD; Novartis; Ono Pharmaceutical; Takeda
 
Danielle de Farias
Honoraria - Amgen; Bristol-Myers Squibb; Janssen; Novartis; Takeda
Consulting or Advisory Role - ABBVIE; Amgen; Bristol-Myers Squibb; Janssen; Mabxience; Novartis; Takeda
Research Funding - ABBVIE; Boehringer Ingelheim; Bristol-Myers Squibb; Celltrion; GlaxoSmithKline; Janssen; Libbs; Millennium; Novartis; Pfizer
 
Richard Labotka
Employment - Millennium
 
Tomas Skacel
Employment - Millennium
 
Antonio Palumbo
Employment - Takeda
Stock and Other Ownership Interests - Takeda
Honoraria - Genmab; Janssen-Cilag; Takeda
Consulting or Advisory Role - Genmab; Janssen-Cilag; Takeda
Research Funding - Genmab (Inst); Janssen-Cilag (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Takeda
 
Sagar Lonial
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Millennium; Novartis; Onyx
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Celgene (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Sanofi (Inst); Takeda (Inst)
 
Meletios A. Dimopoulos
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Genesis Pharmaceuticals; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Takeda
Research Funding - Amgen (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Amgen; Genesis Pharmaceuticals; Janssen-Ortho